Latest Content

FDA to Review Subcutaneous Rybrevant for NSCLC Treatment

June 24th 2024, 3:00pm

By Alex Biese

Article

A Biologics License Application has been filed for the subcutaneous administration of Rybrevant for some patients with non-small cell lung cancer.

Negative Cancer Care Experiences Shaped My Life

June 24th 2024, 1:00pm

By Lorlee Bartos

Article

My health care team went back and forth on whether spots on my liver were cancerous, and that put me on an emotional rollercoaster.

Shifting the Spotlight to Cancer Vaccines

June 23rd 2024, 6:00pm

By Debu Tripathy, M.D.

Article

With many groundbreaking cancer therapies on the horizon, it's also time to focus on up and coming cancer vaccines.

Cancer and the Question of Faith

June 23rd 2024, 2:00pm

By Mike Hennessy Jr.

Article

In the 2024 CURE Summer issue, we focused on a facet of cancer: the question of faith.

Finding Support and Hope After a Rare Cancer Diagnosis

June 22nd 2024, 6:00pm

By Olga Tsoudis

Article

Participating in research and leaning on advocacy organizations helped me through my rare cancer diagnosis.

How Targeted Therapies Changed Lung Cancer Treatment

June 22nd 2024, 2:00pm

By Alex Biese

Article

One expert explains why “the future of precision medicine” has arrived in lung cancer at the CURE® Educated Patient® Lung Cancer Summit.

Having 'Dignity and Respect' During Cancer

June 21st 2024, 9:00pm

By Alex Biese

Article

LGBTQI+ patients with cancer are encouraged to seek positive relationships with care teams despite possible histories of minority stress.

FDA Approves Krazati Plus Erbitux for KRAS-Mutant CRC

June 21st 2024, 6:37pm

By Brielle Benyon

Article

The Food and Drug Administration approved Krazati plus Erbitux for pretreated KRAS G12C-mutant colorectal cancer.

The Importance of Having a Cancer Community

June 21st 2024, 5:00pm

By Natasha Carlson

Article

Being a part of the cancer community means meeting new people, forming personal friendships and fostering those connections for others.

Don Omar Announces Being Cancer Free, ‘General Hospital’ Star Opens Up About Cancer and More

June 21st 2024, 3:27pm

By Ashley Chan

Article

From Don Omar announcing being cancer free to “General Hospital” star John York talking about treatment for his two cancers, here’s what’s going on in the oncology space this week.

A Personalized Approach to Combining Drugs and Surgery for NSCLC

June 21st 2024, 1:00pm

By Brielle Benyon

Article

Tumor characteristics are used to determine the best method of combining therapies with surgery for non-small cell lung cancer, according to a presentation at the CURE® Educated Patient® Lung Cancer Summit.

Earlier Calquence Leads to Improved Survival Outcomes in CLL

June 20th 2024, 9:00pm

By Dylann Cohn-Emery

Article

Patients with chronic lymphocytic leukemia had better survival when treated with Calquence during earlier lines of therapy.

CAR-T Moving to Earlier Availability in Multiple Myeloma

June 20th 2024, 6:00pm

By Alex Biese

Article

During the CURE® Educated Patient® Multiple Myeloma Summit, one expert explained the push to make CAR-T cell therapy available for patients sooner.

Having a Great Primary Care Doctor During Cancer Made a Difference

June 20th 2024, 5:00pm

By Sue McCarthy

Article

My reliable primary care physician was such an important asset in navigating multiple cancers.

Combining Drugs, Radiation Is ‘Practice-Changing’ for Some Lung Cancer Subsets

June 20th 2024, 3:00pm

By Brielle Benyon

Article

Radiation plus targeted or immunotherapies could be beneficial for certain patients with lung cancer, and expert said at the CURE® Educated Patient® Lung Cancer Summit.